Susan Blumel

407 citations
16 papers · 308 indexed · h-index 8
Topics
Chronic Lymphocytic Leukemia Research (14 papers)Lymphoma Diagnosis and Treatment (12 papers)Monoclonal and Polyclonal Antibodies Research (5 papers)
Partner nations
United States

In The Last Decade

Susan Blumel

16 papers receiving 302 citations

Peers

Susan Blumel
Comparison fields: 5 of 29
  • Pathology and Forensic Medicine 247
  • Genetics 172
  • Oncology 167
  • Molecular Biology 78
  • Hematology 60
Replace Sherri Cicero with:
Sherri Cicero United States
A. Ervin-Haynes United States
Roshanak Bob Germany
Jefferson Parker United States
Nichola Webster United Kingdom
Mitul Gandhi United States
Antonella Anastasia Italy
Kimberly Hartig United States
Francesca Maria Quaglia Italy
Felicia Gomez United States
Susan Blumel relative to Sherri Cicero United States Sherri Cicero's profile →
Citations per field
00.5×1.5×1.9×
Sherri Cicero · 1×
Citations per year

Countries citing papers authored by Susan Blumel

Since Specialization
Citations

This map shows the geographic impact of Susan Blumel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Blumel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Blumel more than expected).

Fields of papers citing papers by Susan Blumel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Blumel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Blumel. The network helps show where Susan Blumel may publish in the future.

Co-authorship network of co-authors of Susan Blumel

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Blumel. A scholar is included among the top collaborators of Susan Blumel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Blumel. Susan Blumel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 2
2 1
3 4
4 2
5 9
6 6
7 5
8 7
9 9
10 138
11 36
12 59
13 1
14 9
15 4
16 16

About Susan Blumel

Susan Blumel is a scholar working on Genetics, Pathology and Forensic Medicine and Neurology, having authored 16 papers that have together received 308 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (14 papers), Lymphoma Diagnosis and Treatment (12 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). The work is most often cited by research in Genetics (172 citations), Pathology and Forensic Medicine (247 citations) and Oncology (167 citations). Susan Blumel has collaborated with scholars based in United States. Frequent co-authors include Julie M. Vose, Faith Young, Jennifer L. Kelly, John P. Leonard, Richard I. Fisher, Jonathan W. Friedberg, Jamés O. Armitage, Derick R. Peterson, Steven Grant and Steven H. Bernstein. Their work appears in journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026